ACADIA NATIONAL HEALTH SYSTEMS INC
8-K, 1997-08-14
MISC HEALTH & ALLIED SERVICES, NEC
Previous: YURIE SYSTEMS INC, 10-Q, 1997-08-14
Next: ONSALE INC, 10-Q, 1997-08-14




                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, DC  20549
     
                                   FORM 8-K

                           Current Report Pursuant
                        to Section 13 or 15(d) of the
                       Securities Exchange Act of 1934


                       Date of Report: August 13, 1997


                     ACADIA NATIONAL HEALTH SYSTEMS, INC.
            (Exact Name of Registrant as Specified in its Charter)

                                   COLORADO
               (State or Other Jurisdiction of Incorporation)

            0-28976                                  010509781
      (Commission File Number)         (I.R.S. Employer Identification Number)

   460 Main Street, Lewiston, Maine                    04240
(Address of Principal Executive Offices)            (Zip Code)

                                (207) 777-3423
           (Registrant's Telephone Number, Including Area Code)

<PAGE>  

                    INFORMATION INCLUDED IN THIS REPORT

ITEM 1 CHANGES IN CONTROL OF REGISTRANT

     (a) On Tuesday, July 29, 1997, Paul W. Chute, Chief Executive Officer 
and Chairman of the Board of Directors, and Jacquelyn J. Magno, Vice President
and Secretary of the Board of Directors, collectively purchased a controlling 
interest in the Registrant from Peacock Hill Farm Limited Liability Company 
and the Estate of Thomas N. Hackett, as a result of the death of Thomas N. 
Hackett on May 25, 1997.  The change in control is documented as follows:

July 29, 1997

Names of Persons Who Acquired Control:

Paul W. Chute
RFD #1, Box 2740
Buckfield, ME 04220

Jacquelyn J. Magno
124 Fairway Drive
Auburn, ME 04210

Amount of Consideration Used by Such Persons:


                             $  Amount             Source                    

Paul W. Chute                $203,945.32           Personal Funds

Jacquelyn J. Magno           $196,054.68           Personal Funds 
 

Basis of the Control:

Peacock Hill Farm 
Limited Liability 
Company
(Elaine H. Hackett, 
Direct Ownership 
and Sole Voting 
Authority)

<PAGE>

Previously Owned         Sold to Paul W. Chute      Sold to Jacquelyn J. Magno

2,509,000 Shares
(67.2%) of Class         1,235,687 Shares (33.1%)   1,090,313 Shares (29.2%)


Estate of 
Thomas N. Hackett
(Elaine H. Hackett, 
Personal 
Representative)


Previously Owned         Sold to Paul W. Chute      Sold to Jacquelyn J. Magno

156,000 Shares
(4.4%) of Class          82,875 Shares (2.2%)       73,125 Shares (2.0%)
_______________________________________________________________________________ 

_______________________________________________________________________________ 


The change in control took place on Tuesday, July 29, 1997 at Skelton, 
Taintor & Abbott, P.A., 95 Main Street, Auburn, Maine, 04210.

The mailing address of the Estate of Thomas N. Hackett is C/O Bryan M. Dench, 
Esq., Skelton, Taintor & Abbott, P.A., 95 Main Street, Auburn, Maine 
04212-3200 ("The Estate").

The mailing address of Peacock Hill Farm Limited Liability Company is C/O 
Bryan M. Dench, Esq., Skelton, Taintor & Abbott, P.A., 95 Main Street, 
Auburn, Maine 04212-3200 ("The LLC").

The mailing address of Paul W. Chute is C/O Acadia National Health Systems, 
Inc., 460 Main Street, Lewiston, Maine 04240 ("Chute").

The mailing address of Jacquelyn J. Magno is C/O Acadia National Health 
Systems, Inc., 460 Main Street, Lewiston, Maine 04240 ("Magno").

<PAGE>

Elaine H. Hackett, Personal Representative of the Estate of Thomas N. Hackett 
and Sole Managing Member of Peacock Hill Farm Limited Liability Company 
("Seller") sold to Paul W. Chute, Chairman of the Board of Directors and 
Chief Executive Officer of the Registrant and Jacquelyn J. Magno, Vice 
President and Secretary of the Board of Directors of the Registrant 
(collectively "Purchaser") certain control stock interests held by Seller in 
Acadia National Health Systems, Inc. as follows:
     
     One hundred fifty-six thousand (156,000) shares of 
     Acadia common stock, no par value; 

     Two million three hundred twenty-six thousand (2,326,000) shares of 
     Acadia common stock, no par value. 

     The allocation of the aggregate purchase price will be payable as 
     follows:

                              $ Amount Received         $ Amount Paid     


ESTATE OF 
THOMAS N. HACKETT             $ 281,685.13              -------------

PEACOCK HILL FARM
LIMITED LIABILITY 
COMPANY                       $ 118,314.87              -------------

PAUL W. CHUTE                 --------------            $ 203,945.32

JACQUELYN J. MAGNO            --------------            $ 196,054.68


     Total                    $ 400,000.00              $ 400,000.00
                              ==============            =============

The purchase and sale of the stock interests took place at the offices of 
Skelton, Taintor and Abbott, P.A. 95 Main Street, P.O. Box 3200, Auburn, 
Maine 04212-3200, at 2:00 p.m. on July 29, 1997.

<PAGE>

Instructions:

     2.  The Registrant has released the Estate of Thomas N. Hackett and 
Peacock Hill Farm Limited Liability Company from liability in connection with 
Thomas N. Hackett's (decedent of Estate) personal guaranty of lines of credit 
and a term loan existing between the Registrant and Peoples Heritage Bank 
whose address is 217 Main Street, Lewiston, Maine 04240.  The newly approved 
Lender of the Registrant, Northeast Bank, FSB, whose address is 232 Center 
Street, Auburn, Maine 04210, extended lines of credit to the Registrant.  
These new lines allowed for the release of the lines of credit and term loan 
extended by Peoples Heritage Bank that were personally guaranteed by Mr. 
Hackett. 

Indemnification Agreement.  Mark T. Thatcher, Esq. ("Thatcher"), independent 
counsel to the Registrant, whose business address is Mark T. Thatcher, P.C., 
360 Thames Street, Newport, RI 02840, and Christopher O. Werner ("Werner"), 
advisor to the Registrant, whose business address is 360 Thames Street, 
Newport, RI 02840, personally indemnified and held harmless the Estate and LLC 
from liability that could arise in connection with Acadia's status as a fully 
reporting company under the Securities Exchange Act of 1934 (the "Exchange 
Act").  The Registrant caused Mr. Thatcher and Mr. Werner to execute and 
deliver agreements to the Personal Representative of the Estate regarding 
such restrictions in form and substance satisfactory to the Representative.  

     (b) Beneficial Ownership.

                      PRINCIPAL STOCKHOLDERS

    The following table sets forth the beneficial ownership of the
ownership of Acadia's outstanding common stock on August 13, 
1997 by (i) each director and executive officer of Acadia, 
(ii) all directors and executive officers of Acadia as a group, and 
(iii) each shareholder who was known by the Company to be the
beneficial owner of more than five percent (5%) of the
outstanding shares of Acadia:

<PAGE>

                             Shares of Acadia      
                             Common Stock to be
                             Beneficially Owned          Percent
Name and                     as of the Distrib.          of  
Address                      Record Date                 Class


Paul W. Chute, CEO           1,318,562                   35.3%
460 Main Street
Lewiston, ME 04240

Jacquelyn J. Magno           1,263,438                   33.8%
460 Main Street
Lewiston, ME 04240

Physician Resources, Inc.      300,000                    8.0% 
460 Main Street
Lewiston, ME  04240

Marise and Philip Lebel         14,000                    0.4% 
460 Main Street
Lewiston, Maine 04240

All Directors and            2,596,000                   69.5%   
Executive Officers
As a Group

     Management of Acadia has advised that they may acquire
additional shares of Acadia Common Stock from time to time in the
open market at prices prevailing at the time of such purchases.

ITEMS 2 THROUGH 4, 6 THROUGH 9 NOT APPLICABLE.
 
ITEM 5.     OTHER EVENTS.

     (i) Reference is made to the press release issued to the public by the 
Registrant on July 31, 1997, the text of which is attached hereto as Exhibit 
99.1, for a description of the events reported pursuant to this Form 8-K.

<PAGE>  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                             ACADIA NATIONAL HEALTH SYSTEMS, INC.


                             Mark T. Thatcher 


DATE:  August 13, 1997       By:   /s/ Mark T. Thatcher        
                             Name: Mark T. Thatcher
                             Title: Filing Agent
                         
<PAGE>  

INDEX TO EXHIBITS

Exhibit Description

10.1--Common Stock Purchase Agreement for 156,000 shares of common stock of
      Acadia National Health Systems, Inc.

10.2--Assignment Separate from Certificate and Irrevocable Stock Power for 
      156,000 shares of common stock of Acadia National Health Systems, Inc.

10.3--Opinion of Counsel with respect to transfer of 156,000 shares of common 
      stock of Acadia National Health Systems, Inc.

10.4--Common Stock Purchase Agreement for 2,326,000 shares of common stock 
      of Acadia National Health Systems, Inc.

10.5--Assignment Separate from Certificate and Irrevocable Stock Power for 
      2,326,000 shares of common stock of Acadia National Health 
      Systems, Inc.

10.6--Opinion of Counsel with respect to transfer of 2,326,000 shares of 
      common stock of Acadia National Health Systems, Inc.

20.1--Board of Director's Resolution authorizing new lines of credit and a 
      term loan in connection with canceling personal guaranty and 
      debts of Thomas N. Hackett, founder of the Registrant.

20.2--Opinion of Borrower's Counsel

20.3--Indemnification Agreement (Estate of Thomas N. Hackett)

20.4--Indemnification Agreement (Peacock Hill Farm Limited Liability Company)

99.1--Text of press release dated July 31, 1997



COMMON STOCK PURCHASE AGREEMENT

      THIS COMMON STOCK PURCHASE AGREEMENT is made as of July 29, 1997 by and 
between THE ESTATE OF THOMAS N. HACKETT ("Estate"), hereinafter sometimes 
referred to as "Seller"), and PAUL W. CHUTE and JACQUELYN J. MAGNO 
(hereinafter collectively referred to as the "Purchaser" and/or "Investor").  

WITNESSETH:

     The Estate wants to sell, and the Purchaser wants to purchase Acadia 
National Health Systems, Inc. ("Acadia" or the "Company") common stock (the 
"Shares" or the "Acadia Common Stock") held by the Estate as follows:

One hundred fifty-six thousand (156,000) shares of the Acadia Common Stock, no 
par value, of the Company held by the Estate for the consideration and upon 
the terms and conditions hereinafter set forth.

     NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:


1.  Purchase and Sale

     1.1  Sale and Delivery of the Shares.  Subject to the terms and 
conditions of this Agreement hereinafter set forth, the Purchaser agrees to 
purchase at the Closing, and the Seller agrees to sell and deliver to the 
Purchaser at the Closing, the Shares at a purchase price of seven thousand 
nine hundred thirty-five dollars and thirteen cents ($7,935.13) (the "Purchase 
Price") in cash, which represents a purchase price of $.05086624 per share for 
each of the Shares described above.  

     1.2  Closing.  The purchase and sale of the Shares shall take place at 
the offices of Skelton, Taintor and Abbott, 95 Main Street, P.O. Box 3200, 
Auburn, Maine 04212-3200, at 2:00 p.m. on July 29, 1997, or at such other time 
and place as the Seller and the Purchaser mutually agree upon (which time and 
place are designated the "Closing" and/or "Closing Time").  

     At the Closing, the Seller shall execute stock transfer assignments and 
instructions, to be forwarded to American Securities Transfer, Inc. (the 
"Transfer Agent"), whose corporate address is 938 Quail Street, Suite 101, 
Lakewood, Colorado 80215-5513, to allow for delivery to the Purchaser a 
certificate or certificates, in the following amount to the following 
designated Purchaser:

<PAGE>

                         $ Amount Paid          No. of Shares Received


PAUL W. CHUTE               $    4,215.54          82,875

JACQUELYN J. MAGNO          $    3,719.59          73,125

     The Purchaser shall deliver to Seller at Closing a certified check or 
other instrument by means reasonably acceptable to Seller in the amount of 
$7,935.13.

     1.3  Price Discount.  Seller acknowledges that it is selling the Shares 
at a price below the current market value for the Shares quoted on the 
Over-the-Counter ("OTC") Electronic Bulletin Board, and agrees that such 
discount in price is due to substantial blocks of shares being sold to 
Purchaser.

     2. Representations and Warranties of Seller. Seller represents and 
warrants to Purchaser as follows:

          2.1. The Seller is, and at the Closing Time will be, authorized to 
transfer one hundred fifty-six thousand (156,000) shares of the Acadia Common 
Stock.  Seller has in possession, and, except as hereinafter set forth in this 
Section 2.2, at the Closing Time will have in possession, fully paid and 
non-assessable, 156,000 shares of the Acadia Common Stock. 

          2.2. When sold, transferred and delivered to Purchaser upon payment 
of the Purchase Price therefor, the Shares will be fully paid and 
non-assessable, free and clear of all mortgages, pledges, liens, security 
interests, conditional sale agreements, charges, encumbrances and, except as 
provided by this Agreement, restrictions of every nature. The Shares are, and 
when sold, transferred and delivered to Purchaser under this Agreement will 
be, duly and validly admitted to listing on the Over-the-Counter ("OTC") 
Electronic Bulletin Board. 

               2.2.2. Except as set forth in Schedule A, there has been, and 
prior to the Closing Time there will be, no material adverse change, 
individually or in the aggregate, in the Estate's condition (financial or 
otherwise) or in the Estate's assets, liabilities or business.

               2.2.3. There has been, and prior to the Closing Time there will 
be, no damage, destruction or loss or other events or conditions of any 
character, or any pending litigation or threatened developments, individually 
or in the aggregate, which would materially and adversely affect the Estate's 
condition (financial or otherwise) or the Estate's assets, liabilities or 
business.

<PAGE>

          2.3. Except as set forth in Schedule A attached hereto and 
incorporated by reference herein, there is, and at the Closing Time there will 
be, no material action, suit, proceeding or investigation pending or, to the 
knowledge of the Estate, threatened, against or affecting the Estate or any of 
its assets. The Estate is not, and at the Closing Time will not be, in default 
under or with respect to any judgment, order, writ, injunction or decree of 
any court or of any federal, state, municipal or other governmental authority, 
department, commission, board, agency or other instrumentality. The Estate 
has, and at the Closing Time will have, complied in all material respects with 
all laws, rules, regulations and orders applicable to it; has, and at the 
Closing Time will have, performed in all material respects all of its material 
obligations and duties to be performed by it to the extent required in 
accordance with their respective terms; and is not, and at the Closing Time 
will not be, in default under or in material breach of any material contract, 
agreement, commitment or other instrument to which it is subject or a party or 
under which it is bound.

          2.4. The Seller has not, and at the Closing Time will not have, 
incurred any liability, obligation or duty for any finder's, agent's or 
broker's fee or commission in connection with this Agreement or the 
transactions contemplated hereby.

          2.5. The Estate, pursuant to the power and authority legally vested 
in it, has duly authorized the execution and delivery of this Agreement by the 
Estate, the stock transactions hereby contemplated, and no action, 
confirmation or ratification by other parties to the Estate or by any other 
person, entity or governmental authority is required in connection therewith. 
The Estate has the power and authority to execute and deliver this Agreement, 
to consummate the transactions hereby contemplated and to take all other 
actions required to be taken by it pursuant to the provisions hereof. The 
Estate has taken all actions required by law, or otherwise to authorize the 
execution and delivery of this Agreement and the sale, transfer and delivery 
of the Shares pursuant to the provisions hereof. This Agreement is valid and 
binding upon the Estate in accordance with its terms. Neither the execution 
and delivery of this Agreement nor the consummation of the transactions 
contemplated hereby will constitute a violation or breach of any agreement, 
stipulation, order, writ, injunction, decree, law, rule or regulation 
applicable to the Estate.

          2.6. Neither this Agreement nor any written information, statement, 
list or certificate furnished or to be furnished to Purchaser pursuant to this 
Agreement or in connection with this Agreement or any of the transactions 
contemplated by this Agreement contains or, at the Closing Time, will contain 
any untrue statement of a material fact or omits or, at the Closing Time, will 
omit to state a material fact necessary in order to make the statements 
contained therein, in light of the circumstances in which they are made, not 
misleading.

     3. Representations and Warranties of Purchaser. Purchaser represents and 
warrants to Seller as follows:

<PAGE>

          3.1. The Purchaser has duly authorized the execution and delivery of 
this Agreement by Purchaser and the transactions hereby contemplated, and no 
action, confirmation or ratification by the Purchaser or by any other person, 
entity or governmental authority is required in connection therewith. 
Purchaser has the power and authority to execute and deliver this Agreement, 
to consummate the transactions hereby contemplated and to take all other 
actions required to be taken by it pursuant to the provision, hereof. 
Purchaser has taken all actions required by law, or otherwise to authorize the 
execution and delivery of this Agreement. This Agreement is valid and binding 
upon Purchaser in accordance with its terms. Neither the execution and 
delivery of this Agreement nor the consummation of said transactions will 
constitute any violation or breach of the Purchaser, or any order, writ, 
injunction, decree, law, rule or regulation applicable to Purchaser.

          3.2. Purchaser is not, and at the Closing Time will not be, liable 
or obligated to pay any finder's, agent's or broker's fee or commission to 
Advisor arising out of or in connection with this Agreement or the 
transactions contemplated by this Agreement.

          3.3  Authorization.  The Purchaser is the authorized agent of ACADIA 
NATIONAL HEALTH SYSTEMS, INC.  When executed and delivered by Purchaser, this 
Agreement will constitute the valid and legally binding obligation of 
Purchaser and the Estate.

          3.4  Accredited Investor.  The Purchaser, which has been designated 
in Section 1.2 hereof as the ultimate purchaser of the Shares, are not each an 
"accredited investor" as is defined in Rule 501(a)(3) promulgated under the 
1933 Securities Act.

     4. Conditions Precedent to Obligation and Duty of Purchaser to Acquire 
the Shares. The obligation and duty of Purchaser to purchase from the Seller 
the Shares as contemplated by this Agreement are subject to the fulfillment 
and satisfaction at the Closing Time of each of the following conditions 
precedent, any or all of which may be waived in whole or in part at or prior 
to the Closing Time by Purchaser:

          4.1. All representations and warranties of Seller contained in this 
Agreement and expressly made at the Closing Time shall be true and correct at 
the Closing Time, and all of the other representations and warranties of the 
Seller contained in this Agreement shall be true and correct at the Closing 
Time as though each of such representations and warranties was made at such 
time.

          4.2. The Seller shall have performed and complied with all covenants 
and agreements on Seller's part required by this Agreement to be performed or 
complied with prior to or at the Closing Time.

          4.3. Seller specifically represents and warrants that:


<PAGE>

               4.3.1. When issued, sold, transferred and delivered to 
Purchaser the Shares will be fully paid and non-assessable, free and clear of 
all mortgages, pledges, liens, security interests, conditional sale 
agreements, charges, encumbrances and, except as provided by this Agreement, 
restrictions of every nature.

               4.3.2. Except as set forth on Schedule A to this Agreement, 
Seller does not know of any material action, suit, proceeding or investigation 
pending or threatened against the Seller or affecting the Seller or any of its 
assets.

               4.3.3. To the best knowledge of Seller, the issuance, sale, 
transfer and delivery of the Shares pursuant to the provisions of this 
Agreement will not constitute a violation or breach of any agreement, 
stipulation, order, writ, injunction or decree applicable to the Seller.

5.  Securities Act of 1933 ("Act")

     5.1  Investment Representations.

          (a)  This Agreement is made with Purchaser in reliance upon its 
representations to the Seller and to the Company, which by its acceptance 
hereof Purchaser hereby confirms, that the Shares to be received will be 
acquired by the Purchaser for investment for an indefinite period for their 
own account, and not with a view to the sale or distribution of any part 
thereof in violation of the Act, and that the Purchaser has no present 
intention of selling or otherwise distributing the same without full 
compliance with the rules and regulations promulgated under the Act.  By 
executing this Agreement, Purchaser further represents that to the best of its 
knowledge the Purchaser does not have any existing contract undertaking, 
agreement or arrangement with any person to sell to such person any of the 
Shares.

          (b)  Purchaser understands that the one hundred fifty-six thousand 
(156,000) Shares sold and delivered to Purchaser by Seller are restricted 
shares, and are not being registered under the Act on the ground that the sale 
provided for in this Agreement is exempt pursuant to Section 4(1) and 4(2) of 
the Act and Regulation D thereunder, and that the Seller's reliance on such 
exemption is predicated on Purchaser's representations set forth herein.

          (c)  Purchaser acknowledges that in no event can the Purchaser make 
a disposition of any of the Shares, unless either such Shares are sold by 
Purchaser pursuant to Rule 144 under the Act, or such Shares shall have been 
registered under the Act, or Purchaser shall have furnished the Company with 
an opinion of counsel reasonably satisfactory to the Company to the effect 
that such disposition will not require registration of such securities under 
the Act under the circumstances of such disposition.


<PAGE>

          (d)  Purchaser represents that to the best of its knowledge 
Purchaser is able to fend for itself in the transactions contemplated by this 
Agreement, has such knowledge and experience in financial and business matters 
as to be capable of evaluating the merits and risks of its investment, has the 
ability to bear the economic risks of its investment and has been furnished 
with and has had access to such information as would be made available in the 
form of a registration statement together with such additional information as 
is necessary to verify the accuracy of the information supplied and to have 
all questions which have been asked by the Purchaser answered by the Seller 
and/or by the Company.

          (e)  Purchaser acknowledges that Purchaser understands that if a 
registration statement covering the Shares under the Act is not in effect when 
it desires to sell any of the Shares, Purchaser may be required to hold such 
Shares for an indeterminate period.  Purchaser also acknowledges that it and 
Purchaser understands that any sale of the Shares which might be made by it in 
reliance upon Rule 144 under the Act may be made only in limited amounts in 
accordance with the terms and conditions of that rule.

          (f)  In making its decision to purchase the Shares herein subscribed 
for, Purchaser has relied solely upon independent investigations made by 
Purchaser or its duly appointed and qualified Purchaser Representative.  
Purchaser is not relying on the Seller or the Company, or any person connected 
with the Seller or the Company with respect to the tax, securities and other 
economic considerations involved in this investment.  

          (g)  Purchaser acknowledges that no representations or warranties 
have been made to Purchaser by the Seller or any officer, employee, agent, 
affiliate or any other person connected with the Seller.

          (h)  Purchaser acknowledges, represents, agrees and is aware that 
the representations, warranties, agreements, undertakings and acknowledgments 
made by Purchaser in this Agreement are made with the intent that they be 
relied upon by the Seller in determining Purchaser's suitability as a 
purchaser of the Shares, and shall survive its purchase of the Shares.  In 
addition, Purchaser undertakes to notify the Seller immediately of any change 
in any representation, warranty or other information relating to Purchaser set 
forth herein.  

<PAGE>

     5.2  Legends.  All certificates for the Shares shall bear substantially 
the following legend:

"THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE 
SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED BY THE PURCHASER 
FOR INVESTMENT PURPOSES.  SAID SHARES MAY NOT BE SOLD OR TRANSFERRED UNLESS 
(A) THEY ARE SOLD PURSUANT TO RULE 144 OF THE ACT, OR (B) THEY HAVE BEEN 
REGISTERED UNDER SAID ACT, OR (C) THE TRANSFER AGENT IS PRESENTED WITH A 
WRITTEN OPINION SATISFACTORY TO COUNSEL FOR THE COMPANY TO THE EFFECT THAT 
SUCH REGISTRATION IS NOT REQUIRED UNDER THE CIRCUMSTANCES OF SUCH SALE OR 
TRANSFER."

6.  Conditions to Obligations at Closing.  

     The obligations of each party under this Agreement are subject to the 
representations and warranties of the other party contained herein being true 
on and as of the Closing, and the other party having performed and complied 
with all agreements and conditions contained herein required to be performed 
or complied with by them on or before the Closing.

7.  Miscellaneous

     7.1  Agreement is Entire Contract.  Except as specifically referenced 
herein, this Agreement constitutes the entire contract between the parties 
hereto concerning the subject matter hereof and no party shall be liable or 
bound to the other in any manner by any warranties, representations or 
covenants except as specifically set forth herein.  Any previous agreement 
among the parties related to the transactions described herein is superseded 
hereby.  The terms and conditions of this Agreement shall inure to the benefit 
of and be binding upon the respective successors and assigns of the parties 
hereto, expressly including the Purchaser. Nothing in this Agreement, express 
or implied, is intended to confer upon any party, other than the parties 
hereto, and their respective successors and assigns, any rights, remedies, 
obligations, or liabilities under or by reason of this Agreement, except as 
expressly provided herein.

     7.2  Governing Law.  This Agreement shall be governed by and construed 
under the laws of the State of Maine.

     7.3  Counterparts.  This Agreement may be executed in two or more 
counterparts, each of which shall be deemed an original, but all of which 
together shall constitute one and the same instrument.

<PAGE>

     7.4  Title and Subtitles.  The titles of the paragraphs and subparagraphs 
of this Agreement are for convenience and are not to be considered in 
construing this Agreement.

     7.5  Notices.  Any notice required or permitted hereunder shall be given 
in writing and shall be deemed effectively given upon personal delivery or 
upon deposit in the United States Post Office, by registered or certified 
mail, addressed to a party at its address hereinafter shown below its 
signature or at such other address as such party may designate by ten (10) 
days' advance written notice to the other party.

     7.6  Survival of Warranties.  The warranties and representations of the 
Seller and Purchaser contained in or made pursuant to this Agreement shall 
survive the execution and delivery of this Agreement and the Closing 
hereunder.

SIGNATURE PAGE

     IN WITNESS WHEREOF, the undersigned have executed this Agreement as of 
the day and year first written above.

                              SELLER:

                              ESTATE OF THOMAS N. HACKETT

                              BY______________________________
                              ELAINE H. HACKETT,
                              Personal Representative
                              Address:
                              C/O Skelton, Taintor & Abbott, P.A.
                              95 Main Street
                              P.O. Box 3200
                              Auburn, Maine 04240

                              PURCHASER:

                              By:_____________________________
                              PAUL W. CHUTE     
                              Acadia National Health Systems, Inc.
                              Title: Chief Executive Officer
                              Address:  
                              460 Main Street
                              Lewiston, Maine 04240

<PAGE>


                              By:_____________________________
                              JACQUELYN J. MAGNO
                              Acadia National Health Systems, Inc.
                              Title: VP and Secretary
                              Address:  
                              460 Main Street
                              Lewiston, Maine 04240



ASSIGNMENT SEPARATE FROM CERTIFICATE
AND IRREVOCABLE STOCK POWER

     FOR VALUE RECEIVED, the undersigned does hereby assign and transfer the 
following shares of Acadia National Health Systems, Inc. (the "Company") 
Common Stock, standing in the name of the undersigned on the books of said 
Company:

          82,875 to          Paul W. Chute 
                             RFD #1, Box 2740 
                             Buckfield, ME  04220

          73,125 to          Jacquelyn J. Magno
                             124 Fairway Drive
                             Auburn, ME  04240

          10,000 to          Daniel L. Barnett
                             RFD Box 2600
                             New Vineyard, ME  04956

     The undersigned does hereby irrevocably constitute and appoint the 
Company's transfer agent as attorney to transfer the said stock on the books 
of the transfer agent and the Company, with full power of substitution in the 
premises.

DATED:  July 29, 1997.
                                   ESTATE OF THOMAS N. HACKETT

                                   By:_____________________________
                                   ELAINE H. HACKETT,
                                   PERSONAL REPRESENTATIVE
STATE OF MAINE               )
                             ) ss:
COUNTY OF ANDROSCOGGIN       )

      The signature above is hereby guaranteed by an eligible guarantor 
institution (Bank, Stockbroker, Savings and Loan Association or Credit Union) 
with membership in an approved signature Medallion Program this ____ day of 
______________, 1997.  
                                   Signature guaranteed by:
                                                                  


July 29, 1997

FEDERAL EXPRESS
CONFIDENTIAL

American Securities Transfer, Inc.
As Representative of Acadia National Health Systems, Inc.
938 Quail Street, Suite 101
Lakewood, CO  80215-5513

     Re:     Acadia National Health Systems, Inc. ("Acadia") -
             Restricted Transfer of 166,000 common shares from 
             the Estate of Thomas N. Hackett to Paul W. Chute,           
             Jacquelyn J. Magno and Daniel L. Barnett

Ladies and Gentlemen:

     This office represents Acadia National Health Systems, Inc. ("Acadia").  
I am in receipt of various communications from the Estate of Thomas N. Hackett 
relating to the proposed transfer of 166,000 shares of Acadia common stock 
pursuant to Section 4(1) of the Securities Act of 1933.

     Based on representations contained in these documents, copies of which 
are attached hereto, it is my opinion that you may transfer the 166,000 shares 
of common stock owned by the Estate of Thomas N. Hackett in reliance upon the 
exemption from registration provided for in Section 4(1).

     All shares, when issued, should bear a restricted legend in standard form 
and should not be further transferred without the prior written consent of the 
Company.

     In rendering the above opinion, I have excluded from consideration state 
securities or blue sky laws, except as specifically noted.     My opinion is 
limited to the federal laws of the United States, the laws of the State of 
Colorado and the General Corporation Law of the State of Colorado as 
prescribed by the Colorado Business Corporation Act, and I can assume no 
responsibility with respect to the applicability or effect of the laws of any 
other jurisdiction.  I disclaim any obligation to notify you or any other 
person or entity if any change in fact and/or law should change my opinion 
with respect to any matter on which I am expressing an opinion herein.
 
<PAGE>

    The foregoing opinion is furnished by me as counsel for the Company and is 
solely for your benefit and may not be relied upon by any other person unless 
my prior written consent is obtained.

                                   Respectfully,




                                   Mark T. Thatcher, Esq.
                                   Atty. Reg. No. 25-275


MTT/jet
cc:  Elaine N. Hackett
     Bryan M. Dench, Esq.
     Paul W. Chute, CEO
     Jacquelyn J. Magno
     Daniel L. Barnett



COMMON STOCK PURCHASE AGREEMENT

      THIS COMMON STOCK PURCHASE AGREEMENT is made as of July 29, 1997 by and 
between PEACOCK HILL FARM LIMITED LIABILITY COMPANY ("LLC", hereinafter 
sometimes referred to as "Seller"), and PAUL W. CHUTE and JACQUELYN J. MAGNO 
(hereinafter collectively referred to as the "Purchaser" and/or "Investor").  

WITNESSETH:

     The LLC wants to sell, and the Purchaser wants to purchase Acadia 
National Health Systems, Inc. ("Acadia" or the "Company") common stock (the 
"Shares" or the "Acadia Common Stock") held by the LLC as follows:

Two million three hundred twenty-six thousand (2,326,000) shares of the Acadia 
Common Stock, no par value, of the Company held by the LLC for the 
consideration and upon the terms and conditions hereinafter set forth.

     NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:


1.  Purchase and Sale

     1.1  Sale and Delivery of the Shares.  Subject to the terms and 
conditions of this Agreement hereinafter set forth, the Purchaser agrees to 
purchase at the Closing, and the Seller agrees to sell and deliver to the 
Purchaser at the Closing, the Shares at a purchase price of one hundred 
eighteen thousand three hundred fourteen dollars and eighty-seven cents 
($118,314.87) (the "Purchase Price") in cash, which represents a purchase 
price of $.05086624 per share for each of the Shares described above.  

     1.2  Closing.  The purchase and sale of the Shares shall take place at 
the offices of Skelton, Taintor and Abbott, 95 Main Street, P.O. Box 3200, 
Auburn, Maine 04212-3200, at 2:00 p.m. on July 29, 1997, or at such other time 
and place as the Seller and the Purchaser mutually agree upon (which time and 
place are designated the "Closing" and/or "Closing Time").  

<PAGE>

     At the Closing, the Seller shall execute stock transfer assignments and 
instructions, to be forwarded to American Securities Transfer, Inc. (the 
"Transfer Agent"), whose corporate address is 938 Quail Street, Suite 101, 
Lakewood, Colorado 80215-5513, to allow for delivery to the Purchaser a 
certificate or certificates, in the following amount to the following 
designated Purchaser:

                            $ Amount Paid          No. of Shares Received


PAUL W. CHUTE               $   62,854.77          1,235,687.5             

JACQUELYN J. MAGNO          $   55,460.10          1,090,312.5


     The Purchaser shall deliver to Seller at Closing a certified check or 
other instrument by means reasonably acceptable to Seller in the amount of 
$118,314.87

     1.3  Price Discount.  Seller acknowledges that it is selling the Shares 
at a price below the current market value for the Shares quoted on the 
Over-the-Counter ("OTC") Electronic Bulletin Board, and agrees that such 
discount in price is due to substantial blocks of shares being sold to 
Purchaser.

     2. Representations and Warranties of Seller. Seller represents and 
warrants to Purchaser as follows:

          2.1. The Seller is, and at the Closing Time will be, authorized to 
transfer two million three hundred twenty-six thousand (2,326,000) shares of 
the Acadia Common Stock.  Seller has in possession, and, except as hereinafter 
set forth in this Section 2.2, at the Closing Time will have in possession, 
fully paid and non-assessable, 2,326,000 shares of the Acadia Common Stock. 

          2.2. When sold, transferred and delivered to Purchaser upon payment 
of the Purchase Price therefor, the Shares will be fully paid and 
non-assessable, free and clear of all mortgages, pledges, liens, security 
interests, conditional sale agreements, charges, encumbrances and, except as 
provided by this Agreement, restrictions of every nature. The Shares are, and 
when sold, transferred and delivered to Purchaser under this Agreement will 
be, duly and validly admitted to listing on the Over-the-Counter ("OTC") 
Electronic Bulletin Board. 

               2.2.2. Except as set forth in Schedule A, there has been, and 
prior to the Closing Time there will be, no material adverse change, 
individually or in the aggregate, in the LLC's condition (financial or 
otherwise) or in the LLC's assets, liabilities or business.


<PAGE>

               2.2.3. There has been, and prior to the Closing Time there will 
be, no damage, destruction or loss or other events or conditions of any 
character, or any pending litigation or threatened developments, individually 
or in the aggregate, which would materially and adversely affect the LLC's 
condition (financial or otherwise) or the LLC's assets, liabilities or 
business.

          2.3. Except as set forth in Schedule A attached hereto and 
incorporated by reference herein, there is, and at the Closing Time there will 
be, no material action, suit, proceeding or investigation pending or, to the 
knowledge of the LLC, threatened, against or affecting the LLC or any of its 
assets. The LLC is not, and at the Closing Time will not be, in default under 
or with respect to any judgment, order, writ, injunction or decree of any 
court or of any federal, state, municipal or other governmental authority, 
department, commission, board, agency or other instrumentality. The LLC has, 
and at the Closing Time will have, complied in all material respects with all 
laws, rules, regulations and orders applicable to it; has, and at the Closing 
Time will have, performed in all material respects all of its material 
obligations and duties to be performed by it to the extent required in 
accordance with their respective terms; and is not, and at the Closing Time 
will not be, in default under or in material breach of any material contract, 
agreement, commitment or other instrument to which it is subject or a party or 
under which it is bound.

          2.4. The Seller has not, and at the Closing Time will not have, 
incurred any liability, obligation or duty for any finder's, agent's or 
broker's fee or commission in connection with this Agreement or the 
transactions contemplated hereby.

          2.5. The LLC, pursuant to the power and authority legally vested in 
it, has duly authorized the execution and delivery of this Agreement by the 
LLC, the stock transactions hereby contemplated, and no action, confirmation 
or ratification by other parties to the LLC or by any other person, entity or 
governmental authority is required in connection therewith. The LLC has the 
power and authority to execute and deliver this Agreement, to consummate the 
transactions hereby contemplated and to take all other actions required to be 
taken by it pursuant to the provisions hereof. The LLC has taken all actions 
required by law, or otherwise to authorize the execution and delivery of this 
Agreement and the sale, transfer and delivery of the Shares pursuant to the 
provisions hereof. This Agreement is valid and binding upon the LLC in 
accordance with its terms. Neither the execution and delivery of this 
Agreement nor the consummation of the transactions contemplated hereby will 
constitute a violation or breach of any agreement, stipulation, order, writ, 
injunction, decree, law, rule or regulation applicable to the LLC.

          2.6. Neither this Agreement nor any written information, statement, 
list or certificate furnished or to be furnished to Purchaser pursuant to this 
Agreement or in connection with this Agreement or any of the transactions 
contemplated by this Agreement contains or, at the Closing Time, will contain 
any untrue statement of a material fact or omits or, at the Closing Time, will 
omit to state a material fact necessary in order to make the statements 
contained therein, in light of the circumstances in which they are made, not 
misleading.

<PAGE>

     3. Representations and Warranties of Purchaser. Purchaser represents and 
warrants to Seller as follows:

          3.1. The Purchaser has duly authorized the execution and delivery of 
this Agreement by Purchaser and the transactions hereby contemplated, and no 
action, confirmation or ratification by the Purchaser or by any other person, 
entity or governmental authority is required in connection therewith. 
Purchaser has the power and authority to execute and deliver this Agreement, 
to consummate the transactions hereby contemplated and to take all other 
actions required to be taken by it pursuant to the provision, hereof. 
Purchaser has taken all actions required by law, or otherwise to authorize the 
execution and delivery of this Agreement. This Agreement is valid and binding 
upon Purchaser in accordance with its terms. Neither the execution and 
delivery of this Agreement nor the consummation of said transactions will 
constitute any violation or breach of the Purchaser, or any order, writ, 
injunction, decree, law, rule or regulation applicable to Purchaser.

          3.2. Purchaser is not, and at the Closing Time will not be, liable 
or obligated to pay any finder's, agent's or broker's fee or commission to 
Advisor arising out of or in connection with this Agreement or the 
transactions contemplated by this Agreement.

          3.3  Authorization.  The Purchaser is the authorized agent of ACADIA 
NATIONAL HEALTH SYSTEMS, INC.  When executed and delivered by Purchaser, this 
Agreement will constitute the valid and legally binding obligation of 
Purchaser and the LLC.

          3.4  Accredited Investor.  The Purchaser, which has been designated 
in Section 1.2 hereof as the ultimate purchaser of the Shares, are not each an 
"accredited investor" as is defined in Rule 501(a)(3) promulgated under the 
1933 Securities Act.

     4. Conditions Precedent to Obligation and Duty of Purchaser to Acquire 
the Shares. The obligation and duty of Purchaser to purchase from the Seller 
the Shares as contemplated by this Agreement are subject to the fulfillment 
and satisfaction at the Closing Time of each of the following conditions 
precedent, any or all of which may be waived in whole or in part at or prior 
to the Closing Time by Purchaser:

          4.1. All representations and warranties of Seller contained in this 
Agreement and expressly made at the Closing Time shall be true and correct at 
the Closing Time, and all of the other representations and warranties of the 
Seller contained in this Agreement shall be true and correct at the Closing 
Time as though each of such representations and warranties was made at such 
time.

          4.2. The Seller shall have performed and complied with all covenants 
and agreements on Seller's part required by this Agreement to be performed or 
complied with prior to or at the Closing Time.

<PAGE>

          4.3. Seller specifically represents and warrants that:

               4.3.1. When issued, sold, transferred and delivered to 
Purchaser the Shares will be fully paid and non-assessable, free and clear of 
all mortgages, pledges, liens, security interests, conditional sale 
agreements, charges, encumbrances and, except as provided by this Agreement, 
restrictions of every nature.

               4.3.2. Except as set forth on Schedule A to this Agreement, 
Seller does not know of any material action, suit, proceeding or investigation 
pending or threatened against the Seller or affecting the Seller or any of its 
assets.

               4.3.3. To the best knowledge of Seller, the issuance, sale, 
transfer and delivery of the Shares pursuant to the provisions of this 
Agreement will not constitute a violation or breach of any agreement, 
stipulation, order, writ, injunction or decree applicable to the Seller.

5.  Securities Act of 1933 ("Act")

     5.1  Investment Representations.

          (a)  This Agreement is made with Purchaser in reliance upon its 
representations to the Seller and to the Company, which by its acceptance 
hereof Purchaser hereby confirms, that the Shares to be received will be 
acquired by the Purchaser for investment for an indefinite period for their 
own account, and not with a view to the sale or distribution of any part 
thereof in violation of the Act, and that the Purchaser has no present 
intention of selling or otherwise distributing the same without full 
compliance with the rules and regulations promulgated under the Act.  By 
executing this Agreement, Purchaser further represents that to the best of its 
knowledge the Purchaser does not have any existing contract undertaking, 
agreement or arrangement with any person to sell to such person any of the 
Shares.

          (b)  Purchaser understands that the two million three hundred 
twenty-six thousand (2,326,000) Shares sold and delivered to Purchaser by 
Seller are restricted shares, and are not being registered under the Act on 
the ground that the sale provided for in this Agreement is exempt pursuant to 
Section 4(1) and 4(2) of the Act and Regulation D thereunder, and that the 
Seller's reliance on such exemption is predicated on Purchaser's 
representations set forth herein.

          (c)  Purchaser acknowledges that in no event can the Purchaser make 
a disposition of any of the Shares, unless either such Shares are sold by 
Purchaser pursuant to Rule 144 under the Act, or such Shares shall have been 
registered under the Act, or Purchaser shall have furnished the Company with 
an opinion of counsel reasonably satisfactory to the Company to the effect 
that such disposition will not require registration of such securities under 
the Act under the circumstances of such disposition.
<PAGE>

          (d)  Purchaser represents that to the best of its knowledge 
Purchaser is able to fend for itself in the transactions contemplated by this 
Agreement, has such knowledge and experience in financial and business matters 
as to be capable of evaluating the merits and risks of its investment, has the 
ability to bear the economic risks of its investment and has been furnished 
with and has had access to such information as would be made available in the 
form of a registration statement together with such additional information as 
is necessary to verify the accuracy of the information supplied and to have 
all questions which have been asked by the Purchaser answered by the Seller 
and/or by the Company.

          (e)  Purchaser acknowledges that Purchaser understands that if a 
registration statement covering the Shares under the Act is not in effect when 
it desires to sell any of the Shares, Purchaser may be required to hold such 
Shares for an indeterminate period.  Purchaser also acknowledges that it and 
Purchaser understands that any sale of the Shares which might be made by it in 
reliance upon Rule 144 under the Act may be made only in limited amounts in 
accordance with the terms and conditions of that rule.

          (f)  In making its decision to purchase the Shares herein subscribed 
for, Purchaser has relied solely upon independent investigations made by 
Purchaser or its duly appointed and qualified Purchaser Representative.  
Purchaser is not relying on the Seller or the Company, or any person connected 
with the Seller or the Company with respect to the tax, securities and other 
economic considerations involved in this investment.  

          (g)  Purchaser acknowledges that no representations or warranties 
have been made to Purchaser by the Seller or any officer, employee, agent, 
affiliate or any other person connected with the Seller.

          (h)  Purchaser acknowledges, represents, agrees and is aware that 
the representations, warranties, agreements, undertakings and acknowledgments 
made by Purchaser in this Agreement are made with the intent that they be 
relied upon by the Seller in determining Purchaser's suitability as a 
purchaser of the Shares, and shall survive its purchase of the Shares.  In 
addition, Purchaser undertakes to notify the Seller immediately of any change 
in any representation, warranty or other information relating to Purchaser set 
forth herein.  

<PAGE>

     5.2  Legends.  All certificates for the Shares shall bear substantially 
the following legend:

"THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE 
SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED BY THE PURCHASER 
FOR INVESTMENT PURPOSES.  SAID SHARES MAY NOT BE SOLD OR TRANSFERRED UNLESS 
(A) THEY ARE SOLD PURSUANT TO RULE 144 OF THE ACT, OR (B) THEY HAVE BEEN 
REGISTERED UNDER SAID ACT, OR (C) THE TRANSFER AGENT IS PRESENTED WITH A 
WRITTEN OPINION SATISFACTORY TO COUNSEL FOR THE COMPANY TO THE EFFECT THAT 
SUCH REGISTRATION IS NOT REQUIRED UNDER THE CIRCUMSTANCES OF SUCH SALE OR 
TRANSFER."

6.  Conditions to Obligations at Closing.  

     The obligations of each party under this Agreement are subject to the 
representations and warranties of the other party contained herein being true 
on and as of the Closing, and the other party having performed and complied 
with all agreements and conditions contained herein required to be performed 
or complied with by them on or before the Closing.

7.  Miscellaneous

     7.1  Agreement is Entire Contract.  Except as specifically referenced 
herein, this Agreement constitutes the entire contract between the parties 
hereto concerning the subject matter hereof and no party shall be liable or 
bound to the other in any manner by any warranties, representations or 
covenants except as specifically set forth herein.  Any previous agreement 
among the parties related to the transactions described herein is superseded 
hereby.  The terms and conditions of this Agreement shall inure to the benefit 
of and be binding upon the respective successors and assigns of the parties 
hereto, expressly including the Purchaser. Nothing in this Agreement, express 
or implied, is intended to confer upon any party, other than the parties 
hereto, and their respective successors and assigns, any rights, remedies, 
obligations, or liabilities under or by reason of this Agreement, except as 
expressly provided herein.

     7.2  Governing Law.  This Agreement shall be governed by and construed 
under the laws of the State of Maine.

     7.3  Counterparts.  This Agreement may be executed in two or more 
counterparts, each of which shall be deemed an original, but all of which 
together shall constitute one and the same instrument.

<PAGE>

     7.4  Title and Subtitles.  The titles of the paragraphs and subparagraphs 
of this Agreement are for convenience and are not to be considered in 
construing this Agreement.

     7.5  Notices.  Any notice required or permitted hereunder shall be given 
in writing and shall be deemed effectively given upon personal delivery or 
upon deposit in the United States Post Office, by registered or certified 
mail, addressed to a party at its address hereinafter shown below its 
signature or at such other address as such party may designate by ten (10) 
days' advance written notice to the other party.

     7.6  Survival of Warranties.  The warranties and representations of the 
Seller and Purchaser contained in or made pursuant to this Agreement shall 
survive the execution and delivery of this Agreement and the Closing 
hereunder.

SIGNATURE PAGE

     IN WITNESS WHEREOF, the undersigned have executed this Agreement as of 
the day and year first written above.

                              SELLER:

                              PEACOCK HILL FARM
                              LIMITED LIABILITY COMPANY

                              BY______________________________
                              ELAINE H. HACKETT,
                              Sole Managing Member
                              Address:
                              C/O Skelton, Taintor & Abbott, P.A.
                              95 Main Street
                              P.O. Box 3200
                              Auburn, Maine 04240

                              PURCHASER:

                              By:_____________________________
                              PAUL W. CHUTE     
                              Acadia National Health Systems, Inc.
                              Title: Chief Executive Officer
                              Address:  
                              460 Main Street
                              Lewiston, Maine 04240

<PAGE>

                              By:_____________________________
                              JACQUELYN J. MAGNO
                              Acadia National Health Systems, Inc.
                              Title: VP and Secretary
                              Address:  
                              460 Main Street
                              Lewiston, Maine 04240




ASSIGNMENT SEPARATE FROM CERTIFICATE
AND IRREVOCABLE STOCK POWER

     FOR VALUE RECEIVED, the undersigned does hereby assign and transfer the 
following shares of Acadia National Health Systems, Inc. (the "Company") 
Common Stock, standing in the name of the undersigned on the books of said 
Company:

          1,235,687     to     Paul W. Chute 
                               RFD #1, Box 2740 
                               Buckfield, ME  04220

          1,090,313     to     Jacquelyn J. Magno
                               124 Fairway Drive
                               Auburn, ME  04210

     The undersigned does hereby irrevocably constitute and appoint the 
Company's transfer agent as attorney to transfer the said stock on the books 
of the transfer agent and the Company, with full power of substitution in the 
premises.

DATED:  July 29, 1997.

                                   PEACOCK HILL FARM
                                   LIMITED LIABILITY COMPANY

                                   By:_____________________________
                                   ELAINE H. HACKETT,
                                   SOLE MANAGING MEMBER
STATE OF MAINE               )
                             ) ss:
COUNTY OF ANDROSCOGGIN       )

      The signature above is hereby guaranteed by an eligible guarantor 
institution (Bank, Stockbroker, Savings and Loan Association or Credit Union) 
with membership in an approved signature Medallion Program this ____ day of 
______________, 1997.  

                                   Signature guaranteed by:

                                                                  


July 29, 1997

FEDERAL EXPRESS
CONFIDENTIAL

American Securities Transfer, Inc.
As Representative of Acadia National Health Systems, Inc.
938 Quail Street, Suite 101
Lakewood, CO  80215-5513

     Re:     Acadia National Health Systems, Inc. ("Acadia") -
             Restricted Transfer of 2,326,000 common shares from 
             Peacock Hill Farm, L.L.C. to Paul W. Chute and 
             Jacquelyn J. Magno

Ladies and Gentlemen:

     This office represents Acadia National Health Systems, Inc. ("Acadia").  
I am in receipt of various communications from Peacock Hill Farm, L.L.C. 
relating to the proposed transfer of 2,326,000 shares of Acadia common stock 
pursuant to Section 4(1) of the Securities Act of 1933.

     Based on representations contained in these documents, copies of which 
are attached hereto, it is my opinion that you may transfer the 2,326,000 
shares of common stock owned by Peacock Hill Farm, L.L.C. in reliance upon the 
exemption from registration provided for in Section 4(1).

     All shares, when issued, should bear a restricted legend in standard form 
and should not be further transferred without the prior written consent of the 
Company.

     In rendering the above opinion, I have excluded from consideration state 
securities or blue sky laws, except as specifically noted.     My opinion is 
limited to the federal laws of the United States, the laws of the State of 
Colorado and the General Corporation Law of the State of Colorado as 
prescribed by the Colorado Business Corporation Act, and I can assume no 
responsibility with respect to the applicability or effect of the laws of any 
other jurisdiction.  I disclaim any obligation to notify you or any other 
person or entity if any change in fact and/or law should change my opinion 
with respect to any matter on which I am expressing an opinion herein.

<PAGE>

    The foregoing opinion is furnished by me as counsel for the Company and is 
solely for your benefit and may not be relied upon by any other person unless 
my prior written consent is obtained.

                                   Respectfully,




                                   Mark T. Thatcher, Esq.
                                   Atty. Reg. No. 25-275


MTT/jet
cc:  Bryan M. Dench, Esq.
     Paul W. Chute, CEO



ACADIA NATIONAL HEALTH SYSTEMS, INC.

Board of Directors' Resolution Authorizing
Borrowing from a Bank and the Establishment
of a Line of Credit

     Pursuant to the provisions of the Colorado Business Corporation Act, the 
undersigned, being all of the Directors of ACADIA NATIONAL HEALTH SYSTEMS, 
INC. (hereinafter referred to as "ACADIA" or the "Corporation") do hereby 
waive any and all notice that may be required to be given with respect to a 
meeting of the Directors of the Corporation and do hereby unanimously take, 
ratify, confirm and approve the following action, as of July 24, 1997:

     WHEREAS, this Corporation is in need of funds for its corporate purposes 
and the officers of this Corporation have arranged for financial 
accommodations from NORTHEAST BANK FSB (hereinafter referred to as the 
"Bank"), whose address is 232 Center Street, Auburn, ME  04210, upon terms and 
conditions satisfactory to such officers and to this Board.

     RESOLVED: That this Corporation borrow from the Bank funds up to but not 
exceeding the principal amount of One Hundred Thousand Dollars ($100,000) and 
establish a lines of credit from the Bank up to but not exceeding Four Hundred 
Thousand Dollars ($400,000) and Two Hundred Fifty Thousand Dollars ($250,000), 
respectively (hereinafter referred to as the "Loan" or "Loans"), and that the 
Chief Executive Officer or Treasurer of the Corporation be and such officers 
are hereby authorized and empowered in the name of and on behalf of the 
Corporation (a) to execute, acknowledge and deliver to the Bank the promissory 
note or notes or other instruments of this Corporation evidencing any such 
Loan or Loans or any extensions or renewals thereof, maturing upon such date 
or dates, bearing interest at such rate or rates, in such form, and containing 
such terms and conditions as may be agreed upon by the Bank and said officers, 
the execution, acknowledgment and delivery of any such promissory note or 
notes or other instruments by such corporate officers to be conclusive 
evidence of such agreement.

     RESOLVED: That said officers be and they are hereby authorized and 
empowered in the name of and on behalf of this Corporation to execute, 
acknowledge and deliver to the Bank a Loan Agreement, a Security Agreement and 
a Collateral Assignment of Company Assets in connection with such Loan or 
Loans containing such terms, conditions, covenants and agreements of this 
Corporation as may be agreed upon by the Bank and said officers, the 
execution, acknowledgment and delivery of any such security agreement by such 
corporate officers to be conclusive evidence of such agreement.

<PAGE>

     RESOLVED: That for action of the Bank in reliance thereon, the
Secretary of this Corporation be and is hereby authorized and empowered to 
certify to the Bank a copy of these resolutions and that the Bank may consider 
such officers to continue in office and these resolutions to remain in full 
force and effect until written notice to the contrary shall be received by an 
officer of the Bank.

     RESOLVED: That the Chief Executive Officer of the Corporation be and is 
hereby authorized and directed in the name of the Corporation and upon its 
behalf to accept the Loan Documents and to execute, acknowledge, and deliver 
the acceptance by the Corporation of such Loan Documents.

     RESOLVED, that all other actions taken by the officers of the Corporation 
since the date of the last Annual Minutes of the Board of Directors are hereby 
ratified, approved and confirmed.


     IN WITNESS WHEREOF, the undersigned Directors have evidenced their 
approval of the above proceedings as of the date first above mentioned.


                                   
                                        ________________________________
                                        PAUL W. CHUTE,
                                        Chairman


                                        ________________________________
                                        JACQUELYN J. MAGNO,
                                        Secretary

DATED: July 24, 1997



July 24, 1997

VIA FEDERAL EXPRESS


Sterling G. Williams, Senior V.P.
Northeast Bank
232 Center Street
Auburn, ME  04210

     Re:  Opinion of Borrower's Counsel -     
          Letter re Term Loans, Section Legal Opinions

          $400,000 Line of Credit
          $100,000 Term Loan

          $250,000 Line of Credit 
          (Community Living Options as co-borrowers)

Dear Mr. Williams:

     Pursuant to the terms and conditions provided in your letters dated July 
18, 1997, and in addition to all other requirements more fully described in 
the loan documents between Northeast Bank (hereinafter referred to as 
"Lender"), whose address is 232 Center Street, Auburn, Maine 04210, and Acadia 
National Health Systems, Inc. (hereinafter referred to as "Borrower" or 
"Acadia"), I hereby inform you as follows:

     1.     Acadia is a fully reporting, public corporation as           
defined by Section 12(g) of the Securities Exchange Act of 1934, 
duly organized and validly existing and in good standing under the 
laws of the State of Colorado.

     2.     Acadia has all requisite corporate power to execute,           
acknowledge and deliver the Loan Documents and to perform its 
obligations therein.

<PAGE>

     3.     Acadia has duly and validly authorized the execution,           
delivery, and performance of the Loan Documents and consummation of 
the transactions contemplated thereby.

     4.     The Loan Documents have been duly executed, 
acknowledged, and delivered by Acadia and are the legal, valid 
and binding obligations of Acadia, each enforceable 
against Acadia in accordance with its terms except as such           
enforceability may be limited by general principles of equity, 
bankruptcy, insolvency, moratorium and similar laws relating to 
creditors' rights generally.

     5.     Acadia has taken all corporate action required in order           
to authorize the execution of the Loan Documents.

     6.The current officers and directors of Acadia, as set forth this 24th 
day of 1997, are as follows:

               Paul W. Chute, 
               CEO and Chairman of the Board

               Jacquelyn J. Magno, 
               Vice President, Secretary and Director

               Marise Lebel, 
               Treasurer


     7.     The authorized capital stock of Acadia consists of           
50,000,000 shares of Common Stock, no par value, of which 3,733,987 
shares are issued, and all of such issued shares have been duly and 
validly authorized and issued and are fully paid and non-assessable.

     8.     To the best of my knowledge there are no litigation pro          
ceedings, or governmental investigations or labor disputes pending 
or threatened against or relating to Acadia, its assets, its 
properties or businesses.

<PAGE>

     9.     As to such other matters incident to the issues           
contemplated in connection with the pledging of assets by Acadia as 
collateral for the loans (described more fully in the Loan 
Documents,) I will provide to the Lender whatever further 
documents and information the Lender may reasonably request.


                                   Sincerely,




                                   Mark T. Thatcher
                                   Atty. Reg No. 25275


MTT/jet
cc:  Paul W. Chute
     Jacquelyn J. Magno
     Bryan M. Dench, Esq.
     Elaine H. Hackett
     H. Kelly Matzen, Esq.
     


INDEMNIFICATION AGREEMENT

     THIS AGREEMENT made this 29th day of July, 1997, by and between MARK T. 
THATCHER and CHRISTOPHER O. WERNER (hereinafter collectively referred to as 
"Thatcher and Werner" and/or the "Indemnifying Party"), whose address is 360 
Thames Street, First Floor, Newport, Rhode Island, 02840, and the ESTATE OF 
THOMAS N. HACKETT (hereinafter referred to as the "Estate" and/or the 
"Indemnified Party"), whose administrative address is C/O Bryan M. Dench, 
Esq., Skelton, Taintor & Abbott, 95 Main Street, Auburn, Maine 04212-3200;


WITNESSETH


     Upon execution of the Closing documents and Exhibits attached hereto, the 
transaction will be completed whereby the sale of One Hundred Fifty-Six 
Thousand (156,000) shares of Acadia National Health Systems, Inc. (hereinafter 
referred to as "Acadia") common stock and Seventy-three (73) shares of PRI, 
Inc. (hereinafter referred to as "PRI") common stock is being purchased from 
the Estate by several affiliates of the Company (including present officers 
and directors.)  The transaction is hereby consummated with the execution of 
all documents set forth herein and attached hereto as Exhibits, and involves 
the estate's beneficial ownership of shares of Acadia and PRI's common stock.  
The sale is hereby made pursuant to Section 4(2) of the Securities Act of 1933 
(the "Act") involving the sale of securities not to be made in any public 
offering.

     The Estate acknowledges that, prior to consummation of all transactions 
represented by these closing documents, it was the majority shareholder of 
Acadia National Health Systems, Inc. ("Acadia and/or the "Company").  The 
Estate also acknowledges that it had no interest in continuing to control the 
Board of Directors of the Company nor to retain the majority ownership of the 
Company.  

     Thatcher and Werner acknowledge hereby that they will accept appointment 
to the Board of Directors of Acadia and will also accept appointment by the 
Interim Board to be officers of the Company.  This appointment will 
automatically assign "affiliate" status to both Thatcher and Werner and will 
restrict all common equity holdings they have in the Company, pursuant to Rule 
144 of the Act and Section 13 or 15(d) of the Securities Exchange Act of 1934 
(the "Exchange Act").   

<PAGE>

     In order to provide further assurances to the Estate, and as part of the 
negotiated sale of the Estate's controlling interest, Thatcher and Werner have 
agreed to hold harmless and indemnify the Estate against any liability which 
may arise out of the continued operation, development and expansion of Acadia.

     NOW THEREFORE, IT IS AGREED AS FOLLOWS:

1.  Indemnification:  In consideration of the Estate appointing Thatcher and 
Werner to serve as members of the Board of Directors of Acadia, and to induce 
the consummation of the purchase and sale of the Estate's controlling interest 
in Acadia to present officers of the Company, Thatcher and Werner hereby agree 
to indemnify and hold harmless the Estate against any and all liability, 
claims or causes of action whatsoever arising out of the continued operation, 
development and expansion of Acadia, including reasonable attorneys fees and 
costs incurred in defending any such claims or causes of action; provided, 
however, that this indemnification shall not apply to any intentional acts 
committed by the Estate, which are deemed by a court of law to have been 
fraudulent or in breach of its fiduciary duty to Thatcher and Werner or the 
officers and directors of the Company.

2.  Insurance:  Thatcher and Werner will insure the Estate by purchasing an 
indemnity policy of insurance or bond which may be in the form of specific 
directors and officers insurance ("D&O").  All policies shall be listed in 
Schedule A attached hereto, and the policies and any proceeds received 
thereunder shall be made payable to the Estate for the purposes of this 
Agreement.

Thatcher and Werner shall have the right to take out insurance on the life of 
any Shareholder whenever, in the opinion of either party, additional insurance 
may be required to carry out the obligations under this Agreement.  

Thatcher and Werner shall ensure payment of all premiums on insurance policies 
taken out pursuant to this Agreement and shall give proof of payment to the 
Estate within fifteen (15) days after a written request by the Estate or its 
representative.

<PAGE>

3.     Warranties/Representations:     

(i)     The Indemnifying Party hereby jointly and severally agrees to 
indemnify the Estate and defend and hold it harmless from and against all 
claims, damages, losses, costs, and expenses (including reasonable attorney 
fees, court costs and other expenses incident to any proceeding, investigation 
or any claim, including without limitation in any suit by the Estate against 
the Indemnifying Party) attributable directly or indirectly to the breach by 
the Indemnifying Party of any obligation hereunder or the inaccuracy of any 
representation or warranty made by the Indemnifying Party herein or in any 
instrument delivered pursuant hereto or in connection with the transactions 
contemplated hereby, including, but not limited to, the Schedule.  

(ii)     A claim for indemnification shall be made only by the Estate 
notifying the Indemnifying Party of the existence of the claim for which 
indemnification is sought.  The Estate shall thereafter be entitled, at its 
option, to control, or participate in, any prosecution or defense relating to 
such claim for indemnity (including without limitation decisions to settle or 
appeal) through attorneys and agents of its choosing, all at the expense of 
the Indemnifying Party (except in any suit by the Indemnifying Party against 
the Estate).  The results of any such prosecution or defense shall be binding 
upon the Indemnifying Party and the Estate for purposes of resolving any claim 
for indemnity. 

(iii)Notwithstanding the foregoing, no new notice of claim for indemnity may 
be given by the Estate after July 1, 2002; any claims for indemnity thereafter 
are barred.  Any claims for indemnity, or portions thereof, in excess of the 
aggregate amount of proceeds received from the indemnity policy due to the 
Indemnifying Party and the Estate shall be the joint and several 
responsibility of the Indemnifying Party and paid to the Estate on demand.  
The Indemnifying Party shall not be entitled to indemnity or contribution 
from, or subrogation to or recovery against the Estate with respect to any 
liability of the Indemnifying Party which may arise under this Agreement of 
the transactions contemplated hereby.

<PAGE>

4.     This Agreement shall bind upon and inure to the benefit of the heirs, 
successors and assigns of the parties hereto.


     IN WITNESS WHEREOF, the parties have signed this Agreement this 29th day 
of July, 1997.


                              INDEMNIFYING PARTY



                              By:______________________                         
                                 MARK T. THATCHER


                              By:______________________                        
                                 CHRISTOPHER O. WERNER



                              INDEMNIFIED PARTY
                              (ESTATE OF THOMAS N. HACKETT)



                              By:______________________                         
                                 BRYAN M. DENCH,
                                 Trustee


                              By:______________________                         
                                 EARL B. AUSTIN,
                                 Trustee


                              By:______________________                        
                                 ELAINE H. HACKETT,
                                 Personal Representative


INDEMNIFICATION AGREEMENT

     THIS AGREEMENT made this 29th day of July, 1997, by and between MARK T. 
THATCHER and CHRISTOPHER O. WERNER (hereinafter collectively referred to as 
"Thatcher and Werner" and/or the "Indemnifying Party"), whose address is 360 
Thames Street, First Floor, Newport, Rhode Island, 02840, and PEACOCK HILL 
FARM LIMITED LIABILITY COMPANY (hereinafter referred to as the "LLC" and/or 
the "Indemnified Party"), whose administrative address is C/O Bryan M. Dench, 
Esq., Skelton, Taintor & Abbott, 95 Main Street, Auburn, Maine 04212-3200;


WITNESSETH


     Upon execution of the Closing documents and Exhibits attached hereto, the 
transaction will be completed whereby the sale of Two Million Three Hundred 
Twenty-six Thousand (2,326,000) shares of Acadia National Health Systems, Inc. 
(hereinafter referred to as "Acadia") common stock is being purchased from the 
LLC by several affiliates of the Company (including present officers and 
directors.)  The transaction is hereby consummated with the execution of all 
documents set forth herein and attached hereto as Exhibits, and involves the 
estate's beneficial ownership of shares of Acadia common stock.  The sale is 
hereby made pursuant to Section 4(2) of the Securities Act of 1933 (the "Act") 
involving the sale of securities not to be made in any public offering.

     The LLC acknowledges that, prior to consummation of all transactions 
represented by these closing documents, it was the majority shareholder of 
Acadia National Health Systems, Inc. ("Acadia and/or the "Company").  The LLC 
also acknowledges that it had no interest in continuing to control the Board 
of Directors of the Company nor to retain the majority ownership of the 
Company.  

     Thatcher and Werner acknowledge hereby that they will accept appointment 
to the Board of Directors of Acadia and will also accept appointment by the 
Interim Board to be officers of the Company.  This appointment will 
automatically assign "affiliate" status to both Thatcher and Werner and will 
restrict all common equity holdings they have in the Company, pursuant to Rule 
144 of the Act and Section 13 or 15(d) of the Securities Exchange Act of 1934 
(the "Exchange Act").   

<PAGE>

     In order to provide further assurances to the LLC, and as part of the 
negotiated sale of the LLC's controlling interest, Thatcher and Werner have 
agreed to hold harmless and indemnify the LLC against any liability which may 
arise out of the continued operation, development and expansion of Acadia.


     NOW THEREFORE, IT IS AGREED AS FOLLOWS:


1.  Indemnification:  In consideration of the LLC appointing Thatcher and 
Werner to serve as members of the Board of Directors of Acadia, and to induce 
the consummation of the purchase and sale of the LLC's controlling interest in 
Acadia to present officers of the Company, Thatcher and Werner hereby agree to 
indemnify and hold harmless the LLC against any and all liability, claims or 
causes of action whatsoever arising out of the continued operation, 
development and expansion of Acadia, including reasonable attorneys fees and 
costs incurred in defending any such claims or causes of action; provided, 
however, that this indemnification shall not apply to any intentional acts 
committed by the LLC, which are deemed by a court of law to have been 
fraudulent or in breach of its fiduciary duty to Thatcher and Werner or the 
officers and directors of the Company.


2.  Insurance:  Thatcher and Werner will insure the LLC by purchasing an 
indemnity policy of insurance or bond which may be in the form of specific 
directors and officers insurance ("D&O").  All policies shall be listed in 
Schedule A attached hereto, and the policies and any proceeds received 
thereunder shall be made payable to the LLC for the purposes of this 
Agreement.

Thatcher and Werner shall have the right to take out insurance on the life of 
any Shareholder whenever, in the opinion of either party, additional insurance 
may be required to carry out the obligations under this Agreement.  

Thatcher and Werner shall ensure payment of all premiums on insurance policies 
taken out pursuant to this Agreement and shall give proof of payment to the 
LLC within fifteen (15) days after a written request by the LLC or its 
managing member.

<PAGE>

3.     Warranties/Representations:     

(i)     The Indemnifying Party hereby jointly and severally agrees to 
indemnify the LLC and defend and hold it harmless from and against all claims, 
damages, losses, costs, and expenses (including reasonable attorney fees, 
court costs and other expenses incident to any proceeding, investigation or 
any claim, including without limitation in any suit by the LLC against the 
Indemnifying Party) attributable directly or indirectly to the breach by the 
Indemnifying Party of any obligation hereunder or the inaccuracy of any 
representation or warranty made by the Indemnifying Party herein or in any 
instrument delivered pursuant hereto or in connection with the transactions 
contemplated hereby, including, but not limited to, the Schedule.  

(ii)     A claim for indemnification shall be made only by the LLC notifying 
the Indemnifying Party of the existence of the claim for which indemnification 
is sought.  The LLC shall thereafter be entitled, at its option, to control, 
or participate in, any prosecution or defense relating to such claim for 
indemnity (including without limitation decisions to settle or appeal) through 
attorneys and agents of its choosing, all at the expense of the Indemnifying 
Party (except in any suit by the Indemnifying Party against the LLC).  The 
results of any such prosecution or defense shall be binding upon the 
Indemnifying Party and the LLC for purposes of resolving any claim for 
indemnity. 

(iii)Notwithstanding the foregoing, no new notice of claim for indemnity may 
be given by the LLC after July 1, 2002; any claims for indemnity thereafter 
are barred.  Any claims for indemnity, or portions thereof, in excess of the 
aggregate amount of proceeds received from the indemnity policy due to the 
Indemnifying Party and the LLC shall be the joint and several responsibility 
of the Indemnifying Party and paid to the LLC on demand.  The Indemnifying 
Party shall not be entitled to indemnity or contribution from, or subrogation 
to or recovery against the LLC with respect to any liability of the 
Indemnifying Party which may arise under this Agreement of the transactions 
contemplated hereby.

<PAGE>

4.     This Agreement shall bind upon and inure to the benefit of the heirs, 
successors and assigns of the parties hereto.


     IN WITNESS WHEREOF, the parties have signed this Agreement this 29th day 
of July, 1997.


                    INDEMNIFYING PARTY



                    By:_____________________                                
                       MARK T. THATCHER


                    By:_____________________                                   
                       CHRISTOPHER O. WERNER



                    INDEMNIFIED PARTY 
                    (PEACOCK HILL FARM LIMITED LIABILITY COMPANY)



                    By:_____________________                                   
                       ELAINE H. HACKETT,
                       Sole Managing Member



LEWISTON, Maine--(BW HealthWire)--July 31, 1997--
Acadia National  Health Systems Inc. (OTC BB:ACAD) reported today that 
its management team lead by Paul W. Chute, chief executive officer and  
Jacquelyn J. Magno, vice president have acquired a controlling and  
majority interest in the company. 

Chute "intends to continue with the company's plan of  consolidating through 
acquisitions within the fragmented Physician  Practice and Management 
Consulting (PPMC) industry."   

Acadia National Health Systems Inc. is a PPMC offering its  clients business 
management services that include doctor billing,  operations financing, 
accounting and practice management consulting.  Acadia acquired assets of 
Physician Resources Inc. (PRI) in  September of 1996.  PRI is a twenty-five 
year old doctor billing  company.  Acadia was formed to utilize the PRI 
assets to expand its  multidimensional services nationally through 
acquisitions and financing. 

Chute has reported that, "Acadia has advanced acquisition  discussions with 
several East Coast doctor billing companies as  well as two software 
organizations, which if acquired will create  both vertical and horizontal 
integration of operations and  technologies."  The company has met with 
several financial  institutions to arrange a long term financial relationship 
to assist  the company in the consolidation of this industry. 

CONTACT:  

Acadia National Health Systems Inc. 

Margaret Heath, 207/777-3423 
KEYWORD: MAINE MASSACHUSETTS 

BW1157  JUL 31,1997


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission